Results 11 to 20 of about 7,177,989 (337)

Esophageal Squamous Cell Carcinoma [PDF]

open access: yes, 2020
This volume provides current management and research protocols on oesophageal squamous cell carcinoma. Chapters guide readers through methods on clinical and pathological diagnostics, translational research for oesophageal squamous cell carcinoma, in vitro assays, liquid biopsy for cancer DNA and circulating tumour cells, genomic analysis, mi-RNAs, and
Lam, Alfred K   +2 more
core   +9 more sources

Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China

open access: yesCancer Biology & Medicine, 2017
Esophageal cancer is one of the most fatal diseases worldwide mainly because of its rapid progression and poor prognosis. Although the incidence of esophageal adenocarcinoma has markedly risen in North America and Europe in the past several decades ...
He Liang, Jin-Hu Fan, You-Lin Qiao
doaj   +4 more sources

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

open access: yesNew England Journal of Medicine, 2022
BACKGROUND First-line chemotherapy for advanced esophageal squamous-cell carcinoma results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival benefit over chemotherapy in previously treated patients with advanced esophageal
Satoru Motoyama, Jaffer Ajani, Ken Kato
exaly   +2 more sources

Toripalimab Plus Chemotherapy in Treatment-Naïve, Advanced Esophageal Squamous Cell Carcinoma (JUPITER-06): A Multi-Center Phase 3 Trial

open access: yesCancer Cell, 2022
Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), 514 patients with treatment-naïve advanced ESCC were randomized (1:1) to ...
Yun Fan, Guanghai Dai, Junhe Li
exaly   +2 more sources

Epidemiology of Esophageal Squamous Cell Carcinoma [PDF]

open access: yesGastroenterology, 2017
Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of the 456,000 incident esophageal cancers each year. Regions of high incidence include Eastern to Central Asia, along the Rift Valley in East Africa, and into South Africa.
C. Abnet, M. Arnold, Wen-Qiang Wei
semanticscholar   +3 more sources

Biobanking for Esophageal Squamous Cell Carcinoma

open access: yes, 2020
Biobanking is important and fundamental for research and personalized medicine in patients with esophageal squamous cell carcinoma. The process often involves prospective collection of surgically obtained tissues (tissue banking) as well as serial blood samples (liquid biopsies) from the patients with esophageal squamous cell carcinoma.
Lam, AK, Alfred K. Lam
openaire   +4 more sources

Genome Sequencing in Esophageal Squamous Cell Carcinoma

open access: yes, 2020
Technological advances in the form of next-generation sequencing allow sequencing of large numbers of different DNA sequences in a single/parallel reaction compared to conventional sequencing. It is a powerful tool which has enabled comprehensive characterization of esophageal squamous cell carcinoma.
Pillai, Suja   +2 more
openaire   +6 more sources

Esophageal Papillomatosis Complicated by Squamous Cell Carcinoma

open access: yesCanadian Journal of Gastroenterology, 2009
Esophageal papillomatosis is a very rare condition that is believed to have a benign clinical course. Recent reports underscore the potential development of a malignancy in association with squamous papillomatosis of the esophagus.
Tan Attila   +4 more
doaj   +3 more sources

Effect of Small-molecule Inhibitor CIL56 on Death of Esophageal Squamous Cell Carcinoma Cells

open access: yesZhongliu Fangzhi Yanjiu, 2023
Objective To investigate the role and mechanism of the small-molecule inhibitor CIL56 in the death of esophageal squamous cell carcinoma cells. Methods SRB method and plate-cloning method were used to detect the effect of CIL56 on the proliferation of ...
CHEN Jiaxing, XU Xiaqing, ZHANG Qi
doaj   +1 more source

The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN 2020.

open access: yesGastroenterology, 2022
BACKGROUND & AIMS To provide an overview of the burden of esophageal cancer in 185 countries in 2020 and projections for the year 2040. METHODS Estimates of esophageal cancer cases and deaths were extracted from the GLOBOCAN database for 2020.
E. Morgan   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy